PainChek General Discussion, page-19298

I'm getting the feeling we are in well oversold territory now. Barring any left field annoucements, I think the next catalyst for the share price will be the transition from the government grant money to realised revenue. The next quarterly should start to show this transition and I expect more interest as the revenue number increases.
The company has weathered the pandemic well, and is in a good financial position to continue to hit milestones. Happy to wait out the current share price pressure.
see y'all in 12 months

RI